Ftse Mib
33.435,44
-0,18%
DAX
19.420,42
0,59%
S&P 500
5.969,34
0,35%
NASDAQ
19.003,65
0,16%
Bitcoin
98.726,36
0,69%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NYSE Bio Rad Laboratories Inc (BIO) Bio Rad Laboratories Inc (BIO) Notizie

Bio Rad Laboratories Inc

BIO
332,91
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 10:33:58
Dati in Delay di 15 minuti
Borsa: NYSE
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
21/11/202415:00BWBio-Rad’s Management to Host Investor Meetings at Citi's..
31/10/202414:00BWBio-Rad's Management to Participate in Fireside Chat During..
30/10/202421:15BWBio-Rad Reports Third-Quarter 2024 Financial Results
14/10/202423:30BWBio-Rad to Report Third Quarter 2024 Financial Results on..
30/9/202422:40BWValerio Therapeutics Reports its Half-Year 2024 Financial..
09/9/202412:05IHMARKETNEWSDell, Palantir, and Erie Will Be Added to the S&P 500;..
07/9/202400:43PRNUSPalantir Technologies, Dell Technologies, and Erie Indemnity..
22/8/202422:30BWBio-Rad’s Management to Participate in Fireside Chat During..
20/8/202414:30BWBio-Rad Appoints Jon DiVincenzo President, Chief Operating..
01/8/202422:15BWBio-Rad Reports Second-Quarter 2024 Financial Results
17/7/202422:30BWBio-Rad to Report Second Quarter Financial Results on..
18/6/202400:37EDGAR2Form 3 - Initial statement of beneficial ownership of..
14/6/202419:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/6/202423:50EDGAR2Form 144 - Report of proposed sale of securities
30/5/202415:00BWBio-Rad Names Anette Engelhardt Executive Vice President and..
23/5/202422:15BWBio-Rad’s Management to Participate in Fireside Chat During..
09/5/202422:30EDGAR2Form SD - Specialized disclosure report
08/5/202422:38EDGAR2Form S-8 - Securities to be offered to employees in employee..
08/5/202422:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/5/202422:18EDGAR2Form 8-K - Current report
07/5/202422:15BWBio-Rad Reports First-Quarter 2024 Financial Results
01/5/202415:00BWBio-Rad’s Management to Participate in Fireside Chat During..
26/4/202414:30BWBio-Rad Announces Life Science Group Management Changes
18/4/202415:00BWBio-Rad to Report First Quarter 2024 Financial Results on..
11/4/202423:30GLOBEOncocyte and Bio-Rad Partner on Global Launch of Transplant..
10/4/202422:15BWBio-Rad’s Chief Operating Officer Andrew Last to Retire
20/3/202413:30BWBio-Rad Appoints Roop K. Lakkaraju Executive Vice President,..
22/2/202422:30BWBio-Rad to Participate in Fireside Chat During Citi's 2024..
15/2/202422:15BWBio-Rad Reports Fourth-Quarter and Full-Year 2023 Financial..
24/1/202423:00BWBio-Rad to Report Fourth Quarter and Full Year 2023..
02/1/202422:15BWBio-Rad’s Management to Host Investor Meetings at J.P...
Apertura: Min: Max:
Chiusura: 332,91

La tua Cronologia

NYSE
BIO
Bio Rad Laboratories
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network